{"nctId":"NCT01008319","briefTitle":"Traditional Clomiphene Citrate Administration vs. Stair-step Approach","startDateStruct":{"date":"2009-10"},"conditions":["Ovulatory Dysfunction","Anovulation","Ovulation Induction"],"count":120,"armGroups":[{"label":"Traditional Administration","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: clomiphene citrate"]},{"label":"Stair-Step Administration","type":"EXPERIMENTAL","interventionNames":["Drug: clomiphene citrate"]}],"interventions":[{"name":"clomiphene citrate","otherNames":["Clomid"]},{"name":"clomiphene citrate","otherNames":["Clomid"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Ovulatory dysfunction as evidenced by mid-luteal progesterone less then 3ng/dL, non-biphasic basal body temperature charting, or menstrual history of cycles \\> 35 days.\n* Female patients 18 to 45 years old\n* Six months or greater of unprotected intercourse without pregnancy.\n* Normal TSH and prolactin serum levels\n* Semen analysis of male partner with \\> 15 million motile sperm on semen analysis.\n\n  * NOTE: Must be willing to travel to the Oklahoma City area for treatment.\n\nExclusion Criteria:\n\n* Failure to spontaneously menstruate or to menstruate following progestin administration\n* Allergy or intolerance to the side effects of clomiphene citrate, hCG (human chorionic gonadotropins), or medroxyprogesterone acetate (Provera).\n* Known anatomical defect affecting the uterine cavity including submucosal fibroids or endometrial polyps.\n* Know tubal hydrosalpinx or risk factors for tubal obstruction\n* Known liver dysfunction\n* Known or suspected androgen secreting tumor, cushings disease, or adrenal hyperplasia (congenital or adult onset)\n* Ovarian cyst \\> 20mm or endometrial lining \\>6 mm on trans-vaginal baseline ultrasound.\n* Stage III or IV endometriosis\n* Decreased ovarian reserve as evidenced by antral follicle count less than 6 by Transvaginal ultrasound or a cycle-day-3 serum FSH of \\> 10 uIU/ml.\n* Positive HIV in either the female patient or her partner.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Time to Ovulation With Each Protocol","description":"We hypothesized that time to ovulation would be shorter with stair-step protocol vs. traditional.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31.1","spread":"3.5"},{"groupId":"OG001","value":"21.5","spread":"0.9"}]}]}]},{"type":"SECONDARY","title":"Rate of Ovulation","description":"Rate of ovulation with each dose of clomid within each protocol","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45","spread":null},{"groupId":"OG001","value":"26","spread":null}]},{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"18","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"10","spread":null}]},{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Delivery Outcomes","description":"Proportion of participants that delivered a baby based on which protocol they were randomized to.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"21","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":60},"commonTop":["Vasomotor Flushes (hot flashes)","Headaches","Mood Swings","Pelvic Discomfort","Breast tenderness"]}}}